Role of exogenous and endogenous trophic factors in the regulation of extraocular muscle strength during development

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 10, 2004, Pages 3538-3545

  Chen, Jennifer ^a   Von Bartheld, Christopher S ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CARDIOTROPHIN 1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUTRALIZING ANTIBODY; SOMATOMEDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSECTION; DOSE TIME EFFECT RELATION; EMBRYO; EXTRAOCULAR MUSCLE; EYE DEVELOPMENT; IN VITRO STUDY; MUSCLE CONTRACTILITY; MUSCLE FIBER MEMBRANE CONDUCTANCE; MUSCLE FORCE; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; STRABISMUS; SUPERIOR OBLIQUE MUSCLE; SUPERIOR RECTUS MUSCLE;

ANIMALS; ANTIBODIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHICK EMBRYO; CHICKENS; CYTOKINES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GROWTH SUBSTANCES; HYDROGEN-ION CONCENTRATION; INSULIN-LIKE GROWTH FACTOR I; MUSCLE CONTRACTION; MUSCLE FIBERS; NERVE GROWTH FACTORS; OCULOMOTOR MUSCLES;

EID: 4644298766     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0393     Document Type: Article

References (56)

1. Stidwill D. Epidemiology of strabismus. Ophthalmic Physiol Opt. 1997;17:536-539.
2. Folk ER, Miller MT, Chapman L. Consecutive exotropia following surgery. Br J Ophthalmol. 1983;67:546-548.
3. Simon JW, Price EC, Krohel GB, Poulin RW, Reinecke RD. Anterior segment ischemia following strabismus surgery. J Pediatr Ophthalmol Strabismus. 1984;21:179-185.
4. Cordonnier M, van Nechel C, van den Ende P, Zumaran C, Benammar L. Treatment of strabismus with botulinum toxin. J Fr Ophtalmol. 1994;17:755-768.
5. Porter JD, Baker RS, Ragusa RJ, Brueckner JK. Extraocular muscles: basic and clinical aspects of structure and function. Surv Ophthalmol. 1995:39:451-484.
6. Averbuch-Heller L, Leigh RJ. Medical treatments for abnormal eye movements: pharmacological, optical and immunological strategies. Aust NZ J Ophthalmol. 1997;25:7-13.
7. Mills MD. Perianesthesia care of adult and pediatric strabismus surgery patients. J Perianesth Nurs. 1998;13:16-23.
8. Sendtner M, Pei G, Beck M, Schweizer U, Wiese S. Developmental motoneuron cell death and neurotrophic factors. Cell Tissue Res. 2000;301:71-84.
9. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA. 1998;95:15603-15607.
10. Coleman ME, DeMayo F, Yin KC, et al. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem. 1995;270:12109-12116.
11. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-I prolongs survival in a mouse ALS model. Science. 2003:301:839-842.
12. Barton E, Morris C. Mechanisms and strategies to counter muscle atrophy. J Gerontol A Biol Sci Med Sci. 2003;58:M923-M926.
13. Rotwein P. Insulin-like growth factor action and skeletal muscle growth, an in vivo perspective. Growth Horm IGF Res. 2003;13:303-305.
14. McLoon LK, Christiansen SP. Increasing extraocular muscle strength with insulin-like growth factor II. Invest Ophthalmol Vis Sci. 2003;44:3866-3872.
15. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA. 1995:92:1142-1146.
16. Bordet T, Schmalbruch H, Pettmann B, et al. Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy. J Clin Invest. 1999:104:1077-1085.
17. Oppenheim RW, Wiese S, Prevette D, et al. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J Neurosci. 2001;21:1283-1291.
18. Jennische E, Skottner A, Hansson H. Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol Scand. 1987:129:9-15.
19. Springer JE, Seeburger JL, He J, et al. cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle. Exp Neural. 1995:131:47-52.
20. Chen J, Butowt R, Rind HB, von Bartheld CS. GDNF increases the survival of developing oculomotor neurons through a target-derived mechanism. Mol Cell Neurosci. 2003;24:41-56.
21. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 1994;266:1062-1064.
22. Nguyen QT, Parsadanian AS, Snider WD, Lichtman JW. Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science. 1998;279:1725-1729.
23. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989; 341:149-152.
24. Hofer M, Barde YA. Brain-derived neurotrophic factor prevents neuronal death in vivo. Nature. 1988:331:261-262.
25. Steljes TP, Kinoshita Y, Wheeler EF, Oppenheim RW, von Bartheld CS. Neurotrophic factor regulation of developing avian oculomotor neurons: differential effects of BDNF and GDNF. J Neurobiol. 1999:41:295-315.
26. Ikeda K, Klinkosz B, Greene T, et al. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol. 1995:37:505-511.
27. Tsuzaka K, Ishiyama T, Pioro EP, Mitsumoto H. Role of brain-derived neurotrophic factor in wobbler mouse motor neuron disease. Muscle Nerve. 2001;24:474-480.
28. Maier A, Eldred E, Edgerton VR. Types of muscle fibers in extraocular muscles of birds. Exp Eye Res. 1972;13:255-265.
29. Heaton MB, Wayne DB. Patterns of extraocular innervation by the oculomotor complex in the chick. J Comp Neurol. 1983:216:245-252.
30. Hamburger V, Hamilton H. A series of normal stages in the development of the chick embryo. J Morphol. 1951:88:49-92.
31. von Bartheld CS. Tracing with radiolabeled neurotrophins. Methods Mol Biol. 2001:169:195-216.
32. Renganathan M, Messi ML, Delbono O. Overexpression of IGF-1 exclusively in skeletal muscle prevents age-related decline in the number of dihydropyridine receptors. J Biol Chem. 1998;273:28845-28851.
33. Asmussen G, Gaunitz U. Mechanical properties of the isolated inferior oblique muscle of the rabbit. Pflugers Arch. 1981:392:183-190.
34. Martin-Caraballo M, Dryer SE. Glial cell line-derived neurotrophic factor and target-dependent regulation of large-conductance KCa channels in developing chick lumbar motoneurons. J Neurosci. 2002;22:10201-10208.
35. Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem. 1997;272:30729-30734.
36. Rind HB, von Bartheld CS. Target-derived cardiotrophin-1 and insulin-like growth factor-I promote neurite growth and survival of developing oculomotor neurons. Mol Cell Neurosci. 2002;19:58-71.
37. Stelling J, McVean A. The contractile properties and movement dynamics of pigeon eye muscle. Pflugers Arch. 1988;412:314-321.
38. Khaskiye A, Gardahaut MF, Fournier Le Ray C, et al. Effects of low and high frequency patterns of stimulation on contractile properties, enzyme activities and myosin light chain accumulation in slow and fast denervated muscles of the chicken. Pflugers Arch. 1987;410:433-440.
39. Ueno S, Yokoyama K, Nakagawa M, Araki S. Effects of pH and temperature on force and stiffness of skeletal muscle fibers during contraction and relaxation in relation to musculoskeletal disorders. Ind Health. 2002;40:362-369.
40. Metzger JM, Moss RL. Effects of tension and stiffness due to reduced pH in mammalian fast- and slow-twitch skinned skeletal muscle fibres. J Physiol. 1990;428:737-750.
41. Tsutamoto T, Wada A, Maeda K, et al. Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001 38:1485-1490.
42. Asai S, Saito Y, Kuwahara K, et al. The heart is a source of circulating cardiotrophin-1 in humans. Biochem Biophys Res Commun. 2000:279:320-323.
43. Heaton MB, Kidd K, Bradley D, et al. Prenatal ethanol exposure reduces spinal cord motoneuron number in the fetal rat but does not affect GDNF target tissue protein. Dev Neurosci. 1999;21:444-452.
44. Zwick M, Teng L, Mu X, Springer JE, Davis BM. Overexpression of GDNF induces and maintains hyperinnervation of muscle fibers and multiple end-plate formation. Exp Neural. 2001;171:342-350.
45. Hodgkinson SC, Spencer GS, Bass JJ, Davis SR, Gluckman PD. Distribution of circulating insulin-like growth factor-I (IGF-I) into tissues. Endocrinology. 1991;129:2085-2093.
46. Suliman IA, Lindgren JU, Elhassan AM, Diab KM, Adem A. Effects of short- and long-term rat hind limb immobilization on spinal cord insulin-like growth factor-I and its receptor. Brain Res. 2001;912:17-23.
47. Dimitrova DM, Shall MS, Goldberg SJ. Short-term effects of botulinum toxin on the lateral rectus muscle of the cat. Exp Brain Res. 2002;147:449-455.
48. Christiansen SP, Becker BA, Iaizzo PA, McLoon LK. Extraocular muscle force generation after ricin-mAb35 injection: implications for strabismus treatment. J AAPOS. 2003:7:1-6.
49. Holden AL, Hodos W, Hayes BP, Fitzke FW. Myopia: induced, normal and clinical. Eye. 1988;2(suppl):S242-S256.
50. Lawrence MS, Azar DT. Myopia and models and mechanisms of refractive error control. Ophthalmol Clin North Am. 2002;15:127-133.
51. McDonald NQ, Chao MV. Structural determinants of neurotrophin action. J Biol Chem. 1995;270:19669-19672.
52. Rotwein P, Bichell DP, Kikuchi K. Multifactorial regulation of IGF-I gene expression. Mol Reprod Dev. 1993;35:358-363.
53. Adams GR, McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol. 1998;84:1716-1722.
54. Mitsumoto H, Klinkosz B, Pioro E, et al. Effects of cardiotrophin-1 (CT-1) in a mouse motor neuron disease. Muscle Nerve. 2001;24:769-777.
55. Lynch GS, Cuffe SA, Plant DR, Gregorevic P. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul Disord. 2001;11:260-268.
56. Paul AC, Rosenthal N. Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol. 2002;156:751-760.